A special moment!
Felicitated by legendary Dr Advani under whom I, like many, started Oncology journey, revered teachers Drs Sudeep Gupta & Reena Nair, legends in the audience
Honored to have had the opportunity to walk in your footsteps🙏🙏
Thanks kind words @bagalbp
The long time debate on the use of platinum in TNBC is finally settled ! Congratulations @ACTREC_TMC, @TataMemorial, entire breast DMG for this landmark trial. Platinum improves survival in premenopausal TNBC.
Updated IPD meta-analysis (including ATHENA-MONO data) on efficacy of maintenance PARP inhibitors in newly diagnosed advanced epithelial ovarian cancers,did not show substantial benefit of PARP inhibitors in HRD negative tumors @ACTREC_TMC@BanerjeeSusana@SuyogCancer@ESMO_Open
@seemagulia1@TataMemorial publish the only IPD metaanalysis PARP-inhibitors first-line ovarian cancer! Highly impactful results, clear benefit BRCA-mut or HRD-pos pts, but NOT in BRCA-wt/HRD-neg pts! @jamecancerdoc @AnaOaknin @myESMO@ASCOPost@sujithonco https://t.co/eXGgl26gAt
First line maintenance PARPi in ovarian cancer improves PFS ✅ in BRCA mutant and HRD positive patients and NOT in HRD negatives ❌.
Choosing wisely is the way forward !https://t.co/X9ZW4FunDn @cspramesh@ACTREC_TMC@ICMRDELHI
We congratulate Dr Sudeep Gupta, Director @ACTREC_TMC , on being conferred the Urmil B K Kapoor Oration 2020, by @aiims_nd ! The Oration was delivered today and can be accessed at https://t.co/3iy2Za4Eoi
@TataMemorial@AnuragAgrawalMD
Concerning cardiac effects of #COVID ! Almost 60% patients, many mild disease, had heart inflammation on MRI after recovery! Even if very small fraction have clinical problems, will be large no., given millions infected! Need for vigilance! @JAMACardio
https://t.co/LJutrUU7Bq
Dr Sudhir Nair & colleagues from @TataMemorial@ACTREC_TMC provide compelling evidence of effectiveness & accuracy of symptom-based telephonic follow-up in cancer patients in @JAMAOto ! Hugely important at all times but especially during #COVID
https://t.co/bC6RSZxwt2